Anticoccidial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Drug Class, By Drug Action, By Animal Type, By Distribution Channel By Region and Competition, 2020-2030F

Description

The Global Anticoccidial Drugs Market, valued at USD 1.41 Billion in 2024, is projected to experience a CAGR of 3.96% to reach USD 1.78 Billion by 2030. Anticoccidial drugs are pharmaceutical agents developed to prevent and treat coccidiosis, a parasitic disease primarily impacting the intestinal tracts of livestock, particularly poultry, caused by protozoa of the genus *Eimeria*. The market's growth is fundamentally supported by the escalating global demand for animal protein, leading to intensive farming practices that increase coccidiosis incidence.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.41 Billion
Market Size 2030	USD 1.78 Billion
CAGR 2025-2030	3.96%
Fastest Growing Segment	Companion Animals
Largest Market	North America

Key Market Drivers

The global anticoccidial drugs market experiences significant expansion driven by the escalating prevalence of coccidiosis in livestock and poultry, coupled with a growing global demand for animal protein. The widespread nature of coccidiosis, caused by *Eimeria* protozoa, consistently necessitates effective pharmaceutical interventions to maintain animal health and productivity.

Key Market Challenges

The continuous development of drug-resistant coccidia strains presents a significant impediment to the growth of the Global Anticoccidial Drugs Market. This pervasive issue directly undermines the effectiveness of existing pharmaceutical treatments, necessitating constant innovation and substantial investment in research and development for novel compounds and treatment strategies. As existing drugs become less potent against evolved parasite strains, their market value and utility diminish, compelling manufacturers to shoulder considerable costs for developing new solutions. This prolonged and costly development cycle for effective new drugs, coupled with the shortened effective lifespan of current products due to resistance, directly stifles overall market expansion.

Key Market Trends

The shift towards natural and probiotic-based coccidiosis management represents a significant trend, driven by increasing consumer demand for residue-free animal products and the industry's need to address drug resistance challenges. Producers are increasingly incorporating feed additives, such as probiotics and prebiotics, to foster robust gut health and enhance the animals' natural immunity. This approach reduces reliance on conventional anticoccidial drugs.

Key Market Players

Vetoquinol SA
Zoetis Philippines Inc.
Phibro Animal Health Corporation
Huvepharma, Inc.
Elanco US Inc.
Biochem Pharmaceutical Industries Ltd
Ceva Sante Animale SA
Impextraco NV
Boehringer Ingelheim International GmbH
Merck & Co., Inc.

Report Scope:

In this report, the Global Anticoccidial Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anticoccidial Drugs Market, By Drug Class:

Ionophore
Antibiotic
Sulphonamides
Chemical Derivative
Other Drug Classes

Anticoccidial Drugs Market, By Drug Action:

Coccidiostatic
Coccidiocidal

Anticoccidial Drugs Market, By Animal Type:

Production Animals
Companion Animals

Anticoccidial Drugs Market, By Distribution Channel:

Veterinary Hospitals
Retail Pharmacy
Other Distribution Channels

Anticoccidial Drugs Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Anticoccidial Drugs Market.

Available Customizations:

Global Anticoccidial Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anticoccidial Drugs Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes)
- 5.2.2. By Drug Action (Coccidiostatic, Coccidiocidal)
- 5.2.3. By Animal Type (Production Animals, Companion Animals)
- 5.2.4. By Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America Anticoccidial Drugs Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Drug Class
- 6.2.2. By Drug Action
- 6.2.3. By Animal Type
- 6.2.4. By Distribution Channel
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Anticoccidial Drugs Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Drug Class
    - 6.3.1.2.2. By Drug Action
    - 6.3.1.2.3. By Animal Type
    - 6.3.1.2.4. By Distribution Channel
- 6.3.2. Canada Anticoccidial Drugs Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Drug Class
    - 6.3.2.2.2. By Drug Action
    - 6.3.2.2.3. By Animal Type
    - 6.3.2.2.4. By Distribution Channel
- 6.3.3. Mexico Anticoccidial Drugs Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Drug Class
    - 6.3.3.2.2. By Drug Action
    - 6.3.3.2.3. By Animal Type
    - 6.3.3.2.4. By Distribution Channel

7. Europe Anticoccidial Drugs Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Drug Class
- 7.2.2. By Drug Action
- 7.2.3. By Animal Type
- 7.2.4. By Distribution Channel
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Anticoccidial Drugs Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Drug Class
    - 7.3.1.2.2. By Drug Action
    - 7.3.1.2.3. By Animal Type
    - 7.3.1.2.4. By Distribution Channel
- 7.3.2. France Anticoccidial Drugs Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Drug Class
    - 7.3.2.2.2. By Drug Action
    - 7.3.2.2.3. By Animal Type
    - 7.3.2.2.4. By Distribution Channel
- 7.3.3. United Kingdom Anticoccidial Drugs Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Drug Class
    - 7.3.3.2.2. By Drug Action
    - 7.3.3.2.3. By Animal Type
    - 7.3.3.2.4. By Distribution Channel
- 7.3.4. Italy Anticoccidial Drugs Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Drug Class
    - 7.3.4.2.2. By Drug Action
    - 7.3.4.2.3. By Animal Type
    - 7.3.4.2.4. By Distribution Channel
- 7.3.5. Spain Anticoccidial Drugs Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Drug Class
    - 7.3.5.2.2. By Drug Action
    - 7.3.5.2.3. By Animal Type
    - 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Anticoccidial Drugs Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Drug Class
- 8.2.2. By Drug Action
- 8.2.3. By Animal Type
- 8.2.4. By Distribution Channel
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Anticoccidial Drugs Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Drug Class
    - 8.3.1.2.2. By Drug Action
    - 8.3.1.2.3. By Animal Type
    - 8.3.1.2.4. By Distribution Channel
- 8.3.2. India Anticoccidial Drugs Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Drug Class
    - 8.3.2.2.2. By Drug Action
    - 8.3.2.2.3. By Animal Type
    - 8.3.2.2.4. By Distribution Channel
- 8.3.3. Japan Anticoccidial Drugs Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Drug Class
    - 8.3.3.2.2. By Drug Action
    - 8.3.3.2.3. By Animal Type
    - 8.3.3.2.4. By Distribution Channel
- 8.3.4. South Korea Anticoccidial Drugs Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Drug Class
    - 8.3.4.2.2. By Drug Action
    - 8.3.4.2.3. By Animal Type
    - 8.3.4.2.4. By Distribution Channel
- 8.3.5. Australia Anticoccidial Drugs Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Drug Class
    - 8.3.5.2.2. By Drug Action
    - 8.3.5.2.3. By Animal Type
    - 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Anticoccidial Drugs Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Drug Class
- 9.2.2. By Drug Action
- 9.2.3. By Animal Type
- 9.2.4. By Distribution Channel
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Anticoccidial Drugs Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Drug Class
    - 9.3.1.2.2. By Drug Action
    - 9.3.1.2.3. By Animal Type
    - 9.3.1.2.4. By Distribution Channel
- 9.3.2. UAE Anticoccidial Drugs Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Drug Class
    - 9.3.2.2.2. By Drug Action
    - 9.3.2.2.3. By Animal Type
    - 9.3.2.2.4. By Distribution Channel
- 9.3.3. South Africa Anticoccidial Drugs Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Drug Class
    - 9.3.3.2.2. By Drug Action
    - 9.3.3.2.3. By Animal Type
    - 9.3.3.2.4. By Distribution Channel

10. South America Anticoccidial Drugs Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Drug Class
- 10.2.2. By Drug Action
- 10.2.3. By Animal Type
- 10.2.4. By Distribution Channel
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Anticoccidial Drugs Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Drug Class
    - 10.3.1.2.2. By Drug Action
    - 10.3.1.2.3. By Animal Type
    - 10.3.1.2.4. By Distribution Channel
- 10.3.2. Colombia Anticoccidial Drugs Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Drug Class
    - 10.3.2.2.2. By Drug Action
    - 10.3.2.2.3. By Animal Type
    - 10.3.2.2.4. By Distribution Channel
- 10.3.3. Argentina Anticoccidial Drugs Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Drug Class
    - 10.3.3.2.2. By Drug Action
    - 10.3.3.2.3. By Animal Type
    - 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Anticoccidial Drugs Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Vetoquinol SA
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Zoetis Philippines Inc.
15.3. Phibro Animal Health Corporation
15.4. Huvepharma, Inc.
15.5. Elanco US Inc.
15.6. Biochem Pharmaceutical Industries Ltd
15.7. Ceva Sante Animale SA
15.8. Impextraco NV
15.9. Boehringer Ingelheim International GmbH
15.10. Merck & Co., Inc.